HLA-DR1, -DR5, and -DR8 antigen disparities are associated with acute steroid-resistant rejection and poor kidney graft survival

Transplant Proc. 1991 Feb;23(1 Pt 2):1272-3.

Authors

K Salmela¹, E von Willebrand, L Kyllönen, S Koskimies, H Isoniemi, B Eklund, K Höckerstedt, J Ahonen

Affiliation

¹ 4th Department of Surgery, Helsinki University Central Hospital, Finland.

PMID: 1899160

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antilymphocyte Serum / therapeutic use
Biopsy, Needle
Graft Rejection / drug effects
Graft Survival
HLA-DR Antigens / immunology*
HLA-DR Serological Subtypes
HLA-DR1 Antigen / immunology*
HLA-DR5 Antigen / immunology*
Histocompatibility
Humans
Kidney Transplantation / immunology*
Methylprednisolone / therapeutic use
Muromonab-CD3
Plasmapheresis
Time Factors
Tissue Donors

Substances

Antibodies, Monoclonal
Antilymphocyte Serum
HLA-DR Antigens
HLA-DR Serological Subtypes
HLA-DR1 Antigen
HLA-DR5 Antigen
HLA-DR8 antigen
Muromonab-CD3
Methylprednisolone